randomly assigned 55 patients with biopsy-confirmed NASH and either impaired glucose tolerance or type 2 diabetes to receive a hypocaloric diet plus either pioglitazone (30 mg daily for 2 months ...

US-based Mylan Pharmaceuticals gained FDA approval for 15 milligram, 30 mg and 45 mg pioglitazone tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in ...

Texas researchers randomized 602 patients with impaired glucose tolerance to placebo or pioglitazone (starting dose of 30 mg, titrated to a target of 45 mg daily). Mean follow-up in this industry ...

Participants were randomly allocated to 16 weeks of either active (pioglitazone 30 mg daily) or placebo treatment. One woman in each group withdrew (one pregnancy and one adverse reaction to ...

Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...